Medline (MDLN) Non-Current Deferred Tax Liability (2025 - 2026)
Medline's (MDLN) quarterly Non-Current Deferred Tax Liability came in at $4.0 billion in Q1 2026, up 13.18% on a QoQ basis from $3.5 billion in Q4 2025.
Medline (MDLN) Non-Current Deferred Tax Liability (2025 - 2026) Analysis & Trends
Medline (MDLN) has 2 years of Non-Current Deferred Tax Liability data on file, last reported at $4.0 billion in Q1 2026.
- On a quarterly basis, Non-Current Deferred Tax Liability changed N/A year-over-year to $4.0 billion in Q1 2026; TTM through Mar 2026 was $4.0 billion, a N/A change from a year earlier, with the FY2025 full-year figure at $3.5 billion, changed N/A from the prior year.
- Non-Current Deferred Tax Liability for Q1 2026 stood at $4.0 billion, up from $3.5 billion in the prior quarter.
- Over the last five years, Non-Current Deferred Tax Liability for MDLN reached as high as $4.0 billion in Q1 2026 and fell as low as $3.5 billion in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn |
| 10 | Baxter International | 11.17 Bn | 9.12 Bn | 891.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 28, 2026 | 4.01 Bn |
| Mar 28, 2026 | 4.01 Bn |
| Dec 31, 2025 | 3.54 Bn |
| Dec 31, 2025 | 3.54 Bn |